Press Release – New York, NY – March 1, 2024 – Gregory Sichenzia, founding partner of Sichenzia Ross Ference Carmel LLP, was quoted in a recent piece published by US News and World Report entitled, 7 …
Sichenzia Ross Ference Carmel LLP Represents EF Hutton LLC in $1.5 Million Underwritten Public Offering of NRx Pharmaceuticals
Press Release – New York, NY –February 28, 2024 – Sichenzia Ross Ference Carmel LLP represents EF Hutton LLC in $1.5 million underwritten public offering of NRx Pharmaceuticals (the “Company”) …
Sichenzia Ross Ference Carmel LLP Represents Lexaria Bioscience Corp. in a $3.6 Million Registered Direct Offering
Press Release – New York, NY – February 16, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Lexaria Bioscience Corp. (the “Company”), (NASDAQ: LEXX), a global innovator in …
Sichenzia Ross Ference Carmel LLP Represents Sunshine Biopharma, Inc. in $10.0 Million Underwritten Public Offering of Common Stock
Press Release – New York, NY – February 15, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Sunshine Biopharma, Inc. (NASDAQ: SBFM), a pharmaceutical company offering and …
Sichenzia Ross Ference Carmel LLP Represents ToughBuilt Industries, Inc. in $3.5 Million Public Offering of Common Stock
Press Release – New York, NY – February 15, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented ToughBuilt Industries, Inc. (NASDAQ: TBLT) (the “Company”) in its public …
Sichenzia Ross Ference Carmel LLP Represents Dominari Securities LLC in $5 Million Initial Public Offering of Unusual Machines, Inc.
Press Release – New York, NY – February 15, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Dominari Securities LLC in the initial public offering of Unusual Machines, …
